Display Settings:

Format

Send to:

Choose Destination

    J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Sep 25;777(1-2):261-8.

    Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells.

    Farhan H, Wähälä K, Adlercreutz H, Cross HS.

    Institute of Pathophysiology, University of Vienna Medical School, AKH, Währingergürtel 18-20 A-1090, Vienna, Austria.

    The high ingestion of soybean products in Asian countries has been suggested to be responsible for a reduced incidence of prostate cancer. The mechanism of action, however, is unknown. Our data demonstrate that genistein and some isoflavone metabolites reduce the activity of 25-D3-24-hydroxylase (CYP24) in the human prostate cancer-derived cell line DU-145. CYP24 is also responsible for degradation of the active vitamin D metabolite 1,25-dihydroxyvitamin D3 which is known to be antimitotic and prodifferentiating in prostate cancer cells. High levels of CYP24 frequently found in prostate cancer cells may thus degrade the active metabolite. This could be prevented by ingestion of genistein-containing food such as soybeans.

    PMID: 12270218 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Estrogen (Cenestin®, Enjuvia®, Estrace®, ...)

      Estrogen is used to treat hot flushes ('hot flashes'; sudden strong feelings of heat and sweating) in women who are experiencing menopause ('change of life', the end of monthly menstrual periods). Some brands of estrogen...